Company intelligence / Profile preview

SeqCenter

Pittsburgh, Pennsylvania, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

SeqCenter provides next-generation sequencing services, leveraging Illumina, Oxford Nanopore, and PacBio platforms, serving academic, biotech, diagnostics, government, and agricultural clients worldwide with clinically relevant and research applications. The company has demonstrated high double-digit annual revenue and profit growth, and was acquired in 2024 by ARCHIMED to further support international expansion and technology development.[1][2][3][4][5][6]

Industry: Non-Drug Biotech

Partnerships

Oxford Nanopore Technologies

Beyond the preview

Go deeper on SeqCenter.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SeqCenter.

Explore the full profile